Forian (NASDAQ:FORA) Stock Price Down 0.5% – What’s Next?

Forian Inc. (NASDAQ:FORAGet Free Report)’s stock price was down 0.5% during mid-day trading on Wednesday . The company traded as low as $2.04 and last traded at $2.04. Approximately 4,402 shares changed hands during trading, a decline of 72% from the average daily volume of 15,895 shares. The stock had previously closed at $2.05.

Forian Trading Down 1.0 %

The stock’s 50-day moving average is $2.22 and its 200-day moving average is $2.48. The stock has a market cap of $63.47 million, a price-to-earnings ratio of 41.20 and a beta of 1.09.

Forian (NASDAQ:FORAGet Free Report) last released its quarterly earnings data on Wednesday, August 14th. The company reported ($0.08) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.02) by ($0.06). The firm had revenue of $4.78 million for the quarter, compared to the consensus estimate of $5.26 million. During the same period in the prior year, the firm earned ($0.03) earnings per share.

Institutional Trading of Forian

An institutional investor recently bought a new position in Forian stock. Elser Financial Planning Inc bought a new stake in Forian Inc. (NASDAQ:FORAFree Report) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 711,406 shares of the company’s stock, valued at approximately $1,885,000. Forian accounts for about 0.3% of Elser Financial Planning Inc’s investment portfolio, making the stock its 26th biggest holding. Elser Financial Planning Inc owned 2.28% of Forian as of its most recent filing with the Securities & Exchange Commission. Hedge funds and other institutional investors own 19.25% of the company’s stock.

About Forian

(Get Free Report)

Forian Inc provides a suite of data management capabilities, and information and analytics solutions to optimize and measure operational, clinical, and financial performance for customers in the healthcare and related industries. It develops commercial, real world evidence (RWE), and market access solutions and proprietary data-driven insights, as well as offers data management solutions.

See Also

Receive News & Ratings for Forian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Forian and related companies with MarketBeat.com's FREE daily email newsletter.